Meagher KM - Search Results

1

Meagher KM, Watson S, Suh GA, Virk A. Meagher KM, et al. J Pers Med. 2022 Aug 12;12(8):1308. doi: 10.3390/jpm12081308. J Pers Med. 2022. PMID: 36013256 Free PMC article.

2

Assessing the implications of positive genomic screening results.

Waltz M, Meagher KM, Henderson GE, Goddard KA, Muessig K, Berg JS, Weck KE, Cadigan RJ. Waltz M, et al. Among authors: meagher km. Per Med. 2020 Mar;17(2):101-109. doi: 10.2217/pme-2019-0067. Epub 2020 Mar 3. Per Med. 2020. PMID: 32125936 Free PMC article.

3

Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words?

Meagher KM, Stuttgen Finn K, Curtis SH, Borucki J, Beck AT, Cheema AW, Sharp RR. Meagher KM, et al. Clin Transl Sci. 2022 Mar;15(3):721-731. doi: 10.1111/cts.13193. Epub 2021 Nov 25. Clin Transl Sci. 2022. PMID: 34755460 Free PMC article.

4

Precisely Where Are We Going? Charting the New Terrain of Precision Prevention.

Meagher KM, McGowan ML, Settersten RA Jr, Fishman JR, Juengst ET. Meagher KM, et al. Annu Rev Genomics Hum Genet. 2017 Aug 31;18:369-387. doi: 10.1146/annurev-genom-091416-035222. Epub 2017 Apr 24. Annu Rev Genomics Hum Genet. 2017. PMID: 28441061 Free PMC article. Review.

5

A New Governance Approach to Regulating Human Genome Editing.

Conley JM, Davis AM, Henderson GE, Juengst ET, Meagher KM, Walker RL, Waltz M, Cadigan J. Conley JM, et al. Among authors: meagher km. N C J Law Technol. 2020 Dec;22(2):107-141. N C J Law Technol. 2020. PMID: 34737680 Free PMC article.

6

Why We Should Reexamine the "Golden Age" of Antibiotics in Social Context.

Meagher KM. Meagher KM. AMA J Ethics. 2024 May 1;26(5):E418-428. doi: 10.1001/amajethics.2024.418. AMA J Ethics. 2024. PMID: 38700526 Free article.

7

Reexamining the Ethics of Human Germline Editing in the Wake of Scandal.

Meagher KM, Allyse MA, Master Z, Sharp RR. Meagher KM, et al. Mayo Clin Proc. 2020 Feb;95(2):330-338. doi: 10.1016/j.mayocp.2019.11.018. Mayo Clin Proc. 2020. PMID: 32029087 Review.

8

Going off antiretroviral treatment in a closely monitored HIV "cure" trial: longitudinal assessments of acutely diagnosed trial participants and decliners.

Henderson GE, Waltz M, Meagher K, Cadigan RJ, Jupimai T, Isaacson S, Ormsby NQ, Colby DJ, Kroon E, Phanuphak N, Ananworanich J, Peay HL. Henderson GE, et al. J Int AIDS Soc. 2019 Mar;22(3):e25260. doi: 10.1002/jia2.25260. J Int AIDS Soc. 2019. PMID: 30869203 Free PMC article. Clinical Trial.

9

Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study.

Meagher KM, Curtis SH, Borucki S, Beck A, Srinivasan T, Cheema A, Sharp RR. Meagher KM, et al. Patient Educ Couns. 2021 Feb;104(2):242-249. doi: 10.1016/j.pec.2020.08.023. Epub 2020 Sep 2. Patient Educ Couns. 2021. PMID: 32919825

10

Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.

Henderson GE, Peay HL, Kroon E, Cadigan RJ, Meagher K, Jupimai T, Gilbertson A, Fisher J, Ormsby NQ, Chomchey N, Phanuphak N, Ananworanich J, Rennie S. Henderson GE, et al. J Med Ethics. 2018 Apr;44(4):270-276. doi: 10.1136/medethics-2017-104433. Epub 2017 Nov 10. J Med Ethics. 2018. PMID: 29127137 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page